Registration Strip Icon for discussion Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.

HVO

Hvivo (HVO)

Hvivo Plc
De:
Trier par:
 Showing the most relevant articles for your search:LSE:HVO
DateHeureSourceTitreSymboleSociété
25/07/202308h00UK RegulatoryhVIVO PLC Flu B challenge modelLSE:HVOHvivo Plc
28/06/202315h16Alliance NewsAlliance NewshVIVO inks deal to manufacture human hMPV virus for challenge trialLSE:HVOHvivo Plc
28/06/202308h00UK RegulatoryhVIVO PLC hMPV human challenge modelLSE:HVOHvivo Plc
14/06/202309h00UK RegulatoryhVIVO PLC Director dealingsLSE:HVOHvivo Plc
02/06/202322h42Alliance NewsAlliance NewsIN THE KNOW: hVIVO involvement in drug approval should boost interestLSE:HVOHvivo Plc
23/05/202313h36UK RegulatoryhVIVO PLC Result of AGMLSE:HVOHvivo Plc
28/04/202308h00UK RegulatoryhVIVO PLC Annual Report and Notice of AGMLSE:HVOHvivo Plc
26/04/202316h44Alliance NewsAlliance NewsTRADING UPDATES: Skillcast swings to loss, RM Infrastructure NAV downLSE:HVOHvivo Plc
26/04/202308h00RNS Non-RegulatoryhVIVO PLC FDA Breakthrough and Fast Track for US biotechLSE:HVOHvivo Plc
25/04/202315h39Alliance NewsAlliance NewsEARNINGS SUMMARY: hVIVO sees 30% revenue growth; Next 15 lifts payoutLSE:HVOHvivo Plc
25/04/202308h00UK RegulatoryhVIVO PLC Final resultsLSE:HVOHvivo Plc
19/04/202308h10UK RegulatoryhVIVO PLC Notice of ResultsLSE:HVOHvivo Plc
06/04/202316h54UK RegulatoryhVIVO PLC Holding(s) in CompanyLSE:HVOHvivo Plc
03/04/202313h13Alliance NewsAlliance NewshVIVO touts positive test results from seasonal flu drug, CD388LSE:HVOHvivo Plc
03/04/202308h00RNS Non-RegulatoryhVIVO PLC Positive results from flu human challenge studyLSE:HVOHvivo Plc
29/03/202308h00RNS Non-RegulatoryhVIVO PLC Presentation at World Vaccine CongressLSE:HVOHvivo Plc
23/03/202308h00UK RegulatoryhVIVO PLC Exercise of OptionsLSE:HVOHvivo Plc
16/03/202308h00UK RegulatoryhVIVO PLC Omicron human challenge model updateLSE:HVOHvivo Plc
06/02/202312h00Alliance NewsAlliance NewshVIVO signs GBP6.8 million deal to test RSV antiviral drug candidateLSE:HVOHvivo Plc
06/02/202310h05UK RegulatoryhVIVO PLC Second Price Monitoring ExtnLSE:HVOHvivo Plc
06/02/202310h00UK RegulatoryhVIVO PLC Price Monitoring ExtensionLSE:HVOHvivo Plc
06/02/202308h05UK RegulatoryhVIVO PLC Long Term Incentive Plan / PDMR NotificationLSE:HVOHvivo Plc
06/02/202308h00UK RegulatoryhVIVO PLC GBP6.8m RSV human challenge contract signedLSE:HVOHvivo Plc
25/01/202313h38Alliance NewsAlliance NewshVIVO expecting record year; 2023 orderbook soars by 65% against 2022LSE:HVOHvivo Plc
25/01/202308h00UK RegulatoryhVIVO PLC Trading updateLSE:HVOHvivo Plc
17/01/202317h23Alliance NewsAlliance NewsTRADING UPDATES: hVIVO wins contract; Dev Clever cancels sharesLSE:HVOHvivo Plc
17/01/202308h00RNS Non-RegulatoryhVIVO PLC EUR3.2m Venn contract with global pharma clientLSE:HVOHvivo Plc
04/01/202313h37Alliance NewsAlliance NewsTAKING AIM: Liberum optimistic on hVIVO's RSV vaccine candidateLSE:HVOHvivo Plc
04/01/202311h40Alliance NewsAlliance NewshVIVO signs contract in Asia Pacific to test RSV vaccine candidateLSE:HVOHvivo Plc
04/01/202308h00UK RegulatoryhVIVO PLC GBP5.2m RSV contract and Notice of Trading updateLSE:HVOHvivo Plc
 Showing the most relevant articles for your search:LSE:HVO

Dernières Valeurs Consultées